Developments MedMira receives Breakthrough Device Designation for syphilis antibody test MedMira (TSXV: MIR) has announced that the FDA has granted Breakthrough Device Designation to its Multiplo Complete Syphilis (TP/nTP) Antibody Test. According to MedMira, unlike conventional laboratory-based testing... November 17, 2026